All In Biotech

Drug Trial Radar · NCT03575052

A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease

A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Safety Study of Pimavanserin Therapy in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Last checked: Nov 20, 2026Latest source record: Dec 31, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 784 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

784

Actual

Start

May 21, 2018

Primary completion

May 6, 2022

Study completion May 6, 2022

Sponsor

Lead sponsor
ACADIA Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Jul 2, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety and tolerability of pimavanserin compared to placebo in adult and elderly subjects with neuropsychiatric symptoms related to neurodegenerative disease.

Conditions

  • Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Interventions

  • PimavanserinDrug

    Pimavanserin 34 mg total daily dose, tablets, once daily by mouth (provided as two 17 mg NUPLAZID® tablets)

  • PlaceboDrug

    Placebo, tablets, once daily by mouth (provided as two placebo tablets)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment-emergent Adverse Events (TEAEs)Time frame: Treatment Period: 8 weeks

Locations

104 sites in 12 countries. Site status is shown where the registry gives one.

  • Cognitive Clinical Trials

    Gilbert, Arizona

  • ATP Clinical Research, Inc.

    Costa Mesa, California

  • Syrentis Clinical Research

    Santa Ana, California

  • Indago Research & Health Center Inc

    Hialeah, Florida

  • Reliable Clinical Research, LLC

    Hialeah, Florida

  • Axcess Medical Research

    Loxahatchee Groves, Florida

  • Premier Clinical Research Institute, Inc.

    Miami, Florida

  • Global Medical Institutes

    Miami, Florida

  • Future Care Solution, LLC

    Miami, Florida

  • MediClear Medical & Research Center, Inc.

    Miami, Florida

  • Novel Clinical Research LLC

    Miami, Florida

  • Laszlo J Mate, MD, PA

    North Palm Beach, Florida

  • University of South Florida

    Tampa, Florida

  • Synexus Clinical Research US

    The Villages, Florida

  • Boston Center Memory

    Newton, Massachusetts

  • Cognitive Clinical Trials LLC

    Papillion, Nebraska

  • The NeuroCognitive Institute

    Mount Arlington, New Jersey

  • UNC Hospital

    Chapel Hill, North Carolina

  • Insight Clinical Trials LLC

    Shaker Heights, Ohio

  • Suburban Research Associates

    Media, Pennsylvania

  • Central for Biomedical Research, LLC

    Knoxville, Tennessee

  • Centre for Mental Health Prof. Dr. Ivan Temkov, Lazur Compl., Park Ezero

    Burgas, Bulgaria

  • UMHAT Psych clin for gen psychiatry and addictions

    Pleven, Bulgaria

  • DCC Sv. Vrach and Sv. Sv. Kozma and Damyan

    Sofia, Bulgaria

  • Diagnostic Consultative Centre, 2, N. Vaptzarov Street

    Varna, Bulgaria

  • Diagnostic Consultative Centre-Mladost-Psychiatry, 15, Republika Blvd

    Varna, Bulgaria

  • Mental Health Center Vratza EOOD, 1 Belasitsa St

    Vratsa, Bulgaria

  • Centro de Investigaciones del Sistema Nervioso

    Bogotá, Colombia

  • E.S.E. Hospital Mental de Antioquia

    Bello, Antioquia, Colombia

  • Centr Investigaciones y Proyectos en Neurociencias

    Barranquilla, Atlántico, Colombia

  • Psynapsis Salud Mental S.A.

    Pereira, Risaralda Department, Colombia

  • BRAIN-SOULTHERAPY s.r.o., , Lekarna Jalta, Namesti Jana Masaryka 3113

    Kladno, Czechia

  • Fakultni nemocnice Olomouc

    Olomouc, Czechia

  • A-shine s.r.o./ Lekarna Centrum

    Pilsen, Czechia

  • AD71, s.r.o.,/Hostivarska Iekarna

    Prague, Czechia

  • Axon Clinical

    Prague, Czechia

  • Neuropsychiatrie, s.r.o., Lekarna 6ka, Fajtlova 1

    Prague, Czechia

  • AD71, s.r.o., /,Lekarna DPS Recruiting

    Říčany, Czechia

  • Petre Sarajishvili Institute of Neurology LLC

    Tbilisi, Georgia

  • Pineo Medical Ecosystem LTD

    Tbilisi, Georgia

Showing 40 of 104 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.